Literature DB >> 17379817

Usefulness of checking platelet count before thrombolysis in acute ischemic stroke.

Brett L Cucchiara1, Bryon Jackson, Mark Weiner, Steven R Messe.   

Abstract

BACKGROUND AND
PURPOSE: Thrombolysis for acute ischemic stroke is strikingly time sensitive. Current guidelines require confirmation of a platelet count > or =100,000 before thrombolysis; however, obtaining this laboratory test may delay treatment.
METHODS: We queried our hospital database to identify patients with ICD-9 codes consistent with acute ischemic stroke from 2000 to 2005 and to determine platelet counts in these patients. Medical charts of patients with platelet counts <100,000 were reviewed to determine whether the patient had a known history of thrombocytopenia or conditions associated with thrombocytopenia.
RESULTS: A total of 1752 patients were identified, and 82 (4.7%) had a platelet count <100,000 at stroke onset. Only 6/1752 (0.3%) had a platelet count <100,000 which was not suspected based on initial history. All of these 6 patients had only mildly decreased platelet counts.
CONCLUSIONS: An unsuspected platelet count <100,000 was found in 0.3% of patients at stroke presentation. In patients without a history of thrombocytopenia or predisposing factors, the benefit of earlier thrombolysis may outweigh the bleeding risk of inadvertently treating a patient with thrombocytopenia.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17379817     DOI: 10.1161/STROKEAHA.106.480889

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  10 in total

1.  Emergency management of acute ischemic stroke.

Authors:  Neelofer Shafi; Joshua M Levine
Journal:  Curr Atheroscler Rep       Date:  2010-07       Impact factor: 5.113

2.  Acute Middle Cerebral Artery Occlusion Treated by Thrombectomy in a Patient with Myelodysplastic Syndrome and Severe Thrombocytopenia.

Authors:  Halil Onder; E Murat Arsava; Anıl Arat; M Akif Topcuoglu
Journal:  J Vasc Interv Neurol       Date:  2015-10

3.  A randomised controlled trial of antiplatelet therapy in combination with Rt-PA thrombolysis in ischemic stroke: rationale and design of the ARTIS-Trial.

Authors:  S M Zinkstok; M Vermeulen; J Stam; R J de Haan; Y B Roos
Journal:  Trials       Date:  2010-05-12       Impact factor: 2.279

4.  Unsuspected coagulopathy rarely prevents IV thrombolysis in acute ischemic stroke.

Authors:  N S Rost; S Masrur; M A Pervez; A Viswanathan; L H Schwamm
Journal:  Neurology       Date:  2009-11-25       Impact factor: 9.910

Review 5.  Alteplase Treatment in Acute Stroke: Incorporating Food and Drug Administration Prescribing Information into Existing Acute Stroke Management Guide.

Authors:  Bart M Demaerschalk
Journal:  Curr Atheroscler Rep       Date:  2016-08       Impact factor: 5.113

6.  European Stroke Organisation (ESO) guidelines on intravenous thrombolysis for acute ischaemic stroke.

Authors:  Eivind Berge; William Whiteley; Heinrich Audebert; Gian Marco De Marchis; Ana Catarina Fonseca; Chiara Padiglioni; Natalia Pérez de la Ossa; Daniel Strbian; Georgios Tsivgoulis; Guillaume Turc
Journal:  Eur Stroke J       Date:  2021-02-19

7.  A Case Report of Recombinant Tissue Plasminogen Activator Use in a SPAN-100-Positive Geriatric Patient with Thrombocytopenia.

Authors:  Ilya Bragin; Justine M Chen
Journal:  Cureus       Date:  2017-12-11

8.  Three easily-implementable changes reduce median door-to-needle time for intravenous thrombolysis by 23 minutes.

Authors:  Demi Tran; Zhu Zhu; Mohammad Shafie; Hermelinda Abcede; Dana Stradling; Wengui Yu
Journal:  BMC Neurol       Date:  2019-11-26       Impact factor: 2.474

9.  EHA Guidelines on Management of Antithrombotic Treatments in Thrombocytopenic Patients With Cancer.

Authors:  Anna Falanga; Avi Leader; Chiara Ambaglio; Zsuzsa Bagoly; Giancarlo Castaman; Ismail Elalamy; Ramon Lecumberri; Alexander Niessner; Ingrid Pabinger; Sebastian Szmit; Alice Trinchero; Hugo Ten Cate; Bianca Rocca
Journal:  Hemasphere       Date:  2022-07-13

10.  Factors delaying intravenous thrombolytic therapy in acute ischaemic stroke: a systematic review of the literature.

Authors:  Angelos Sharobeam; Brett Jones; Dianne Walton-Sonda; Christian J Lueck
Journal:  J Neurol       Date:  2020-03-21       Impact factor: 4.849

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.